Raymond James & Associates’s Stevanato STVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.63M Buy
281,455
+50,380
+22% +$1.01M ﹤0.01% 1579
2024
Q2
$4.24M Sell
231,075
-39,059
-14% -$909K ﹤0.01% 1698
2024
Q1
$8.67M Buy
270,134
+64,730
+32% +$1.97M 0.01% 1245
2023
Q4
$5.61M Buy
205,404
+8,088
+4% +$233K ﹤0.01% 1462
2023
Q3
$5.86M Buy
197,316
+1,806
+0.9% +$56.5K ﹤0.01% 1359
2023
Q2
$6.33M Buy
195,510
+1,288
+0.7% +$36.2K 0.01% 1328
2023
Q1
$5.03M Buy
194,222
+988
+0.5% +$21.2K ﹤0.01% 1456
2022
Q4
$3.47M Sell
193,234
-9,993
-5% -$166K ﹤0.01% 1666
2022
Q3
$3.44M Buy
203,227
+58,090
+40% +$977K ﹤0.01% 1620
2022
Q2
$2.29M Buy
145,137
+71,694
+98% +$1.18M ﹤0.01% 1908
2022
Q1
$1.48M Sell
73,443
-5,120
-7% -$89.3K ﹤0.01% 2343
2021
Q4
$1.76M Buy
78,563
+293
+0.4% +$6.95K ﹤0.01% 2262
2021
Q3
$1.98M Buy
+78,270
New +$1.84M ﹤0.01% 2112

Other funds holding STVN

Raymond James & Associates's STVN Position: Q3 2024 in Review

Raymond James & Associates increased its Stevanato (STVN) stake by 22% in Q3 2024, buying an estimated $1.01M and bringing the position to 281,455 shares worth $5.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

Raymond James & Associates first reported a position in STVN in Q3 2021 and has held it in 13 quarters since. The position peaked at $8.67M in Q1 2024. 131 funds tracked by Wall St. Rank hold STVN as of Q3 2024.

  • Raymond James & Associates held 281,455 shares of Stevanato worth $5.63M as of Q3 2024.
  • Raymond James & Associates bought 50,380 Stevanato shares in Q3 2024, an estimated $1.01M.
  • Stevanato made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1579 holding.
  • Raymond James & Associates first reported a position in Stevanato in Q3 2021 and has held it in 13 quarters since.
  • Raymond James & Associates's Stevanato position peaked at $8.67M in Q1 2024.
  • 131 funds tracked by Wall St. Rank held Stevanato as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.